These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 10375114

  • 1. B-lineage lymphoblastic lymphoma is a clinicopathologic entity distinct from other histologically similar aggressive lymphomas with blastic morphology.
    Soslow RA, Baergen RN, Warnke RA.
    Cancer; 1999 Jun 15; 85(12):2648-54. PubMed ID: 10375114
    [Abstract] [Full Text] [Related]

  • 2. Lymphoblastic lymphoma.
    Cortelazzo S, Ponzoni M, Ferreri AJ, Hoelzer D.
    Crit Rev Oncol Hematol; 2011 Sep 15; 79(3):330-43. PubMed ID: 21273093
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of the efficiency of CHOP-based regimen with or without high dose consolidation treatment combined with hematopoietic stem cell transplantation in 63 lymphoblastic lymphoma patients].
    Qin Y, Shi YK, He XH, Han XH, Zhou SY, Liu P, Yang JL, Yang S, Zhang CG, Dong M, Zhou LQ, Wang JW, Feng FY, Sun Y.
    Zhonghua Zhong Liu Za Zhi; 2009 Jun 15; 31(6):469-73. PubMed ID: 19950562
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May 15; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 6. Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study.
    Bassan R, Pogliani E, Lerede T, Fabris P, Rossi G, Morandi S, Casula P, Lambertenghi-Deliliers G, Vespignani M, Izzi T, Coser P, Corneo G, Barbui T.
    Haematologica; 1999 Dec 15; 84(12):1088-93. PubMed ID: 10586210
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Report of 18 cases lymphoblastic lymphoma].
    Zhang X, Lu Z, Feng X.
    Zhonghua Xue Ye Xue Za Zhi; 1998 Nov 15; 19(11):566-8. PubMed ID: 11263338
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
    Mora J, Filippa DA, Qin J, Wollner N.
    Cancer; 2003 Sep 15; 98(6):1283-91. PubMed ID: 12973853
    [Abstract] [Full Text] [Related]

  • 12. The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence.
    Burkhardt B, Zimmermann M, Oschlies I, Niggli F, Mann G, Parwaresch R, Riehm H, Schrappe M, Reiter A, BFM Group.
    Br J Haematol; 2005 Oct 15; 131(1):39-49. PubMed ID: 16173961
    [Abstract] [Full Text] [Related]

  • 13. T-cell lymphoblastic lymphoma and T-cell acute lymphoblastic leukemia: a separate entity?
    Hoelzer D, Gökbuget N.
    Clin Lymphoma Myeloma; 2009 Oct 15; 9 Suppl 3():S214-21. PubMed ID: 19778844
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Primary non-Hodgkin's lymphoma of the paranasal sinuses: a report of 14 cases].
    Su ZY, Zhang DS, Zhu MQ, Shi YX, Jiang WQ.
    Ai Zheng; 2007 Aug 15; 26(8):919-22. PubMed ID: 17697560
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY, Sun XF, Yan SL, He LR, Zhen ZJ, Xia Y.
    Ai Zheng; 2007 Apr 15; 26(4):418-22. PubMed ID: 17430665
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma].
    Sun XF, Su YS, Liu DG, Jiang WQ, He YJ, Lin TY, Huang HQ, Zhang L, Xia ZJ, Li YH, Zhou ZM, Chen XQ, Xia Y, Zhen ZJ, Guan ZZ.
    Ai Zheng; 2004 Aug 15; 23(8):933-8. PubMed ID: 15301718
    [Abstract] [Full Text] [Related]

  • 20. Clinical presentation, evolution, and prognosis of precursor B-cell lymphoblastic lymphoma in trials LMT96, EORTC 58881, and EORTC 58951.
    Ducassou S, Ferlay C, Bergeron C, Girard S, Laureys G, Pacquement H, Plantaz D, Lutz P, Vannier JP, Uyttebroeck A, Bertrand Y.
    Br J Haematol; 2011 Feb 15; 152(4):441-51. PubMed ID: 21210776
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.